Michael R Harrison

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Metastatic Renal Cell Carcinoma

Chronic Kidney Disease

Small Cell Lung Cancer

Top Venues

Prostate cancer and prostatic diseases

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard, Monika Anand, Daniel J George, Tian Zhang, William R Berry, W Robert Lee, Michael R Harrison, Paul G Corn, Andrew J Armstrong
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer. Prostate cancer and prostatic diseases (2024)
Erik D Hanson, Mohamdod Alzer, Jackson Carver, Cameron K Stopforth, Alexander R Lucas, Young E Whang, Matthew I Milowsky, David Christopher Bartlett, Michael R Harrison, Rhonda L Bitting, Allison M Deal, Lee Stoner, A C Hackney, Claudio L Battaglini
Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2022)
Landon C Brown, Susan Halabi, Jason A Somarelli, Michael Humeniuk, Yuan Wu, Taofik Oyekunle, Lauren E Howard, Jiaoti Huang, Monika Anand, Catrin Davies, Prekshaben Patel, Janet Staats, Kent J Weinhold, Michael R Harrison, Tian Zhang, Daniel J George, Andrew J Armstrong
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer. Prostate cancer and prostatic diseases 25 (4) (2022)
Michael R Harrison, Paul G Davis, Michel G Khouri, David Christopher Bartlett, Rajan T Gupta, Andrew J Armstrong, Megan A McNamara, Tian Zhang, Monika Anand, Kelly Onyenwoke, Sara Edwardson, Danielle Craig, Meghan Michalski, Yuan Wu, Taofik Oyekunle, Brian Coyne, Aubrie Coburn, Lee W Jones, Daniel J George
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND). Prostate cancer and prostatic diseases 25 (1) (2022)
Tracy L Rose, Michael R Harrison, Allision M Deal, Sundhar Ramalingam, Young E Whang, Blaine Brower, Mary Dunn, Chelsea K Osterman, Hillary M Heiling, Marc A Bjurlin, Angela B Smith, Matthew E Nielsen, Hung-Jui Tan, Eric Wallen, Michael E Woods, Daniel J George, Tian Zhang, Anthony Drier, William Y Kim, Matthew I Milowsky
Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, Ulka Vaishampayan, Sumanta Kumar Pal, Yousef Zakharia, Heather S L Jim, Mayer N Fishman, Ana M Molina, Christos E Kyriakopoulos, Che-Kai Tsao, Leonard J Appleman, Benjamin A Gartrell, Arif Hussain, Walter M Stadler, Neeraj Agarwal, Russell K Pachynski, Thomas E Hutson, Hans J Hammers, Christopher W Ryan, Brant A Inman, Jack Mardekian, Azah Borham, Daniel J George
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). Cancer 127 (13) (2021)
Ryan S Chiang, Ashton A Connor, Brant A Inman, Wen-Chi Foo, David N Howell, John F Madden, Matthew J Ellis, Aparna S Rege, Michael R Harrison
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor. Case reports in urology 2020 (2020)
Andrew J Armstrong, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel Costin Danila, Patrick Healy, Monika Anand, William R Berry, Tian Zhang, Michael R Harrison, Changxue Lu, Yan Chen, Giuseppe Galletti, Joseph D Schonhoft, Howard I Scher, Richard Wenstrup, Scott T Tagawa, Emmanuel S Antonarakis, Daniel J George, Susan Halabi
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 4 (2020)